OBJECTIVE: The emerging dimensional approach to classification and treatment of psychiatric disorders calls for better understanding of diagnosis-related variations in psychiatric syndromes and for proper validation of psychometric scales used for the evaluation of those syndromes. This study tested the hypothesis that negative and depressive syndromes as measured by the Positive and Negative Syndrome Scale (PANSS) are consistent across different diagnoses. METHOD: We administered the PANSS to subjects with schizophrenia (n = 305), organic brain disease (OBD, n = 66) and major depressive disorder (MDD, n = 75). Confirmatory factor analysis (CFA) was used to establish if the PANSS items for negative symptoms and for depression fit the hypothesized factor structure and if the item factor loadings were similar among the diagnostic groups. RESULTS: The negative and depressive symptom subscales fit well according to a variety of fit indexes for all groups individually after some modest model modification. However, multisample modeling procedures indicated that the pattern of factor loadings was significantly different among the groups in most cases. CONCLUSION: The results of this study indicate diagnosis-related variations in the negative and depressive syndrome dimensions in schizophrenia, OBD and MDD. These results also validate limited use of the PANSS for evaluation of negative and depressive syndromes in disorders other than schizophrenia. Larger studies are warranted to further evaluate clinical and nosologic significance of diagnostic categories, dimensions and structures of psychiatric syndromes. 2009 S. Karger AG, Basel.
OBJECTIVE: The emerging dimensional approach to classification and treatment of psychiatric disorders calls for better understanding of diagnosis-related variations in psychiatric syndromes and for proper validation of psychometric scales used for the evaluation of those syndromes. This study tested the hypothesis that negative and depressive syndromes as measured by the Positive and Negative Syndrome Scale (PANSS) are consistent across different diagnoses. METHOD: We administered the PANSS to subjects with schizophrenia (n = 305), organic brain disease (OBD, n = 66) and major depressive disorder (MDD, n = 75). Confirmatory factor analysis (CFA) was used to establish if the PANSS items for negative symptoms and for depression fit the hypothesized factor structure and if the item factor loadings were similar among the diagnostic groups. RESULTS: The negative and depressive symptom subscales fit well according to a variety of fit indexes for all groups individually after some modest model modification. However, multisample modeling procedures indicated that the pattern of factor loadings was significantly different among the groups in most cases. CONCLUSION: The results of this study indicate diagnosis-related variations in the negative and depressive syndrome dimensions in schizophrenia, OBD and MDD. These results also validate limited use of the PANSS for evaluation of negative and depressive syndromes in disorders other than schizophrenia. Larger studies are warranted to further evaluate clinical and nosologic significance of diagnostic categories, dimensions and structures of psychiatric syndromes. 2009 S. Karger AG, Basel.
Authors: George S Zubenko; Wendy N Zubenko; Susan McPherson; Eleanor Spoor; Deborah B Marin; Martin R Farlow; Glenn E Smith; Yonas E Geda; Jeffrey L Cummings; Ronald C Petersen; Trey Sunderland Journal: Am J Psychiatry Date: 2003-05 Impact factor: 18.112
Authors: Matthew S Milak; Dmitry B Aniskin; Daniel P Eisenberg; Alexander Prikhojan; Lisa J Cohen; Samantha S Yard; Igor I Galynker Journal: Cogn Behav Neurol Date: 2007-06 Impact factor: 1.600
Authors: Robert M Roth; Laura A Flashman; Andrew J Saykin; Thomas W McAllister; Robert Vidaver Journal: Am J Psychiatry Date: 2004-01 Impact factor: 18.112
Authors: E Daneluzzo; L Arduini; O Rinaldi; M Di Domenico; C Petruzzi; A Kalyvoka; A Rossi Journal: Schizophr Res Date: 2002-07-01 Impact factor: 4.939
Authors: Sean M Murphy; Michael G McDonell; Sterling McPherson; Debra Srebnik; Frank Angelo; John M Roll; Richard K Ries Journal: Drug Alcohol Depend Date: 2015-05-14 Impact factor: 4.492
Authors: Jie-Yu Chuang; Graham K Murray; Antonio Metastasio; Nuria Segarra; Roger Tait; Jenny Spencer; Hisham Ziauddeen; Robert B Dudas; Paul C Fletcher; John Suckling Journal: Front Psychiatry Date: 2014-08-27 Impact factor: 4.157
Authors: Chantelle J Giesbrecht; Norm O'Rourke; Olga Leonova; Verena Strehlau; Karine Paquet; Fidel Vila-Rodriguez; William J Panenka; G William MacEwan; Geoffrey N Smith; Allen E Thornton; William G Honer Journal: PLoS One Date: 2016-03-21 Impact factor: 3.240
Authors: Raffaella Calati; Charles B Nemeroff; Jorge Lopez-Castroman; Lisa J Cohen; Igor Galynker Journal: Int J Neuropsychopharmacol Date: 2020-04-21 Impact factor: 5.176